FDA OKs Paradise Renal Denervation System for Hypertension

After a positive FDA panel review in August, the FDA has approved the Paradise Ultrasound Renal Denervation system for the treatment of hypertension, manufacturer Recor and parent company Otsuka announced.

Related Keywords

Japan ,Boston ,Massachusetts ,United States ,Naomi Fisher ,Division Of Endocrinology ,Recor Medical Inc ,Drug Administration ,Harvard Medical School ,Otsuka Medical Devices Co Ltd ,Symplicity Spyral Renal Denervation System Medtronic Inc ,Paradise Ultrasound Renal Denervation ,Systems Device ,Symplicity Spyral Renal Denervation System ,Hypertension ,Renal Denervation ,Myocardial Infarction ,Ultrasonography ,Ultrasound ,Monogram ,Blood ,Arteries ,Antihypertensive ,Nerves ,Resistant Hypertension ,Esistant Htn ,Uncontrolled Hypertension ,Endocrinology ,Ndocrine System ,Europe ,European ,Us Food And Drug Administration ,Nited States Food And Drug Administration ,Fda ,Hospitals ,Medical Innovations ,Nnovations In Medicine ,Uncontrolled Hypert ,